In Vivo Expression of Reprogramming Factor OCT4 Ameliorates Myelination Deficits and Induces Striatal Neuroprotection in Huntington’s Disease
Open Access
Abstract
White matter atrophy has been shown to precede the massive loss of striatal GABAergic neurons in Huntington’s disease (HD). This study investigated the effects of in vivo expression of reprogramming factor octamer-binding transcription factor 4 (OCT4) on neural stem cell (NSC) niche activation in the subventricular zone (SVZ) and induction of cell fate specific to the microenvironment of HD. R6/2 mice randomly received adeno-associated virus 9 (AAV9)-OCT4, AAV9-Null, or phosphate-buffered saline into both lateral ventricles at 4 weeks of age. The AAV9-OCT4 group displayed significantly improved behavioral performance compared to the control groups. Following AAV9-OCT4 treatment, the number of newly generated NSCs and oligodendrocyte progenitor cells (OPCs) significantly increased in the SVZ, and the expression of OPC-related genes and glial cell-derived neurotrophic factor (GDNF) significantly increased. Further, amelioration of myelination deficits in the corpus callosum was observed through electron microscopy and magnetic resonance imaging, and striatal DARPP32+ GABAergic neurons significantly increased in the AAV9-OCT4 group. These results suggest that in situ expression of the reprogramming factor OCT4 in the SVZ induces OPC proliferation, thereby attenuating myelination deficits. Particularly, GDNF released by OPCs seems to induce striatal neuroprotection in HD, which explains the behavioral improvement in R6/2 mice overexpressing OCT4.Keywords
All Related Versions
Funding Information
- the National Research Foundation of Korea (2019R1I1A1A01057970)
- the Ministry of Health & Welfare, Republic of Korea (HI16C1012)
This publication has 83 references indexed in Scilit:
- Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse BrainPLOS ONE, 2013
- Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1 Contributes to Dysmyelination in Experimental Models of Huntington's DiseaseJournal of Neuroscience, 2011
- Oligodendrogenesis in the subventricular zone and the role of epidermal growth factorBrain Research Reviews, 2011
- Oct4-Induced Reprogramming Is Required for Adult Brain Neural Stem Cell Differentiation into Midbrain Dopaminergic NeuronsPLOS ONE, 2011
- Lake-Front Property: A Unique Germinal Niche by the Lateral Ventricles of the Adult BrainNeuron, 2011
- Amygdala circuitry mediating reversible and bidirectional control of anxietyNature, 2011
- Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysisThe Lancet Neurology, 2011
- Genetic dissection of an amygdala microcircuit that gates conditioned fearNature, 2010
- Impaired adult olfactory bulb neurogenesis in the R6/2 mouse model of Huntington's diseaseBMC Neuroscience, 2010
- Direct reprogramming of human neural stem cells by OCT4Nature, 2009